JP2020505075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505075A5 JP2020505075A5 JP2019561375A JP2019561375A JP2020505075A5 JP 2020505075 A5 JP2020505075 A5 JP 2020505075A5 JP 2019561375 A JP2019561375 A JP 2019561375A JP 2019561375 A JP2019561375 A JP 2019561375A JP 2020505075 A5 JP2020505075 A5 JP 2020505075A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- seq
- antigen
- binding portion
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1701351.7 | 2017-01-27 | ||
| GBGB1701351.7A GB201701351D0 (en) | 2017-01-27 | 2017-01-27 | Binding agents |
| GB1713296.0 | 2017-08-18 | ||
| GBGB1713296.0A GB201713296D0 (en) | 2017-08-18 | 2017-08-18 | Binding agents |
| PCT/GB2018/050239 WO2018138521A1 (en) | 2017-01-27 | 2018-01-26 | Binding agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505075A JP2020505075A (ja) | 2020-02-20 |
| JP2020505075A5 true JP2020505075A5 (enExample) | 2021-03-11 |
| JP7169296B2 JP7169296B2 (ja) | 2022-11-10 |
Family
ID=61132825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019561375A Expired - Fee Related JP7169296B2 (ja) | 2017-01-27 | 2018-01-26 | 結合剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10457736B2 (enExample) |
| EP (1) | EP3574013A1 (enExample) |
| JP (1) | JP7169296B2 (enExample) |
| KR (1) | KR20190112299A (enExample) |
| CN (1) | CN110475787A (enExample) |
| AU (1) | AU2018213124A1 (enExample) |
| BR (1) | BR112019015453A2 (enExample) |
| CA (1) | CA3051797A1 (enExample) |
| IL (1) | IL268288A (enExample) |
| MX (1) | MX2019008905A (enExample) |
| RU (1) | RU2019125975A (enExample) |
| SG (1) | SG11201906963QA (enExample) |
| WO (1) | WO2018138521A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102123322B1 (ko) | 2019-11-01 | 2020-06-16 | 주식회사 미래에스엠 | 상판 오픈형 다용도 선반 |
| KR20210132400A (ko) | 2020-04-27 | 2021-11-04 | 유미경 | 다용도 선반 |
| TW202246334A (zh) * | 2021-02-02 | 2022-12-01 | 美商美國禮來大藥廠 | Gitr拮抗劑及其使用方法 |
| CN116782942A (zh) * | 2021-02-02 | 2023-09-19 | 伊莱利利公司 | Gitr拮抗剂和使用其的方法 |
| JP7671092B2 (ja) * | 2021-05-10 | 2025-05-01 | メディマブバイオ インコーポレイテッド | 抗ｇｉｔｒ抗体およびその用途 |
| US11981727B2 (en) * | 2021-08-31 | 2024-05-14 | Novelmed Therapeutics, Inc | Monospecific and bispecific antibodies and antigen binding fragments thereof |
| WO2023060144A1 (en) * | 2021-10-05 | 2023-04-13 | Lanier Biotherapeutics | Monoclonal antibodies to il-25 and uses thereof |
| WO2023175614A1 (en) | 2022-03-15 | 2023-09-21 | Yeda Research And Development Co. Ltd. | Anti glucocorticoid-induced tnfr-related (gitr) protein antibodies and uses thereof |
| CN118050505B (zh) * | 2024-04-15 | 2024-06-21 | 南京佰抗生物科技有限公司 | 一种多联检荧光免疫层析检测卡 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5238936B2 (ja) * | 2005-03-25 | 2013-07-17 | ジーアイティーアール，インク． | Ｇｉｔｒ結合分子およびその使用 |
| IN2015DN02826A (enExample) * | 2009-09-03 | 2015-09-11 | Merck Sharp & Dohme | |
| TW201605896A (zh) * | 2013-08-30 | 2016-02-16 | 安美基股份有限公司 | Gitr抗原結合蛋白 |
| LT3148579T (lt) * | 2014-05-28 | 2021-05-25 | Agenus Inc. | Anti-gitr antikūnai ir jų panaudojimo būdai |
| PL3151921T3 (pl) * | 2014-06-06 | 2020-02-28 | Bristol-Myers Squibb Company | Przeciwciała przeciwko receptorowi indukowanego glukokortykoidami czynnika martwicy nowotworu (gitr) i ich zastosowania |
| MA41044A (fr) * | 2014-10-08 | 2017-08-15 | Novartis Ag | Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer |
-
2018
- 2018-01-26 KR KR1020197025095A patent/KR20190112299A/ko not_active Ceased
- 2018-01-26 SG SG11201906963QA patent/SG11201906963QA/en unknown
- 2018-01-26 WO PCT/GB2018/050239 patent/WO2018138521A1/en not_active Ceased
- 2018-01-26 RU RU2019125975A patent/RU2019125975A/ru unknown
- 2018-01-26 EP EP18702550.7A patent/EP3574013A1/en not_active Withdrawn
- 2018-01-26 BR BR112019015453-1A patent/BR112019015453A2/pt not_active IP Right Cessation
- 2018-01-26 JP JP2019561375A patent/JP7169296B2/ja not_active Expired - Fee Related
- 2018-01-26 MX MX2019008905A patent/MX2019008905A/es unknown
- 2018-01-26 CA CA3051797A patent/CA3051797A1/en active Pending
- 2018-01-26 CN CN201880020490.8A patent/CN110475787A/zh active Pending
- 2018-01-26 AU AU2018213124A patent/AU2018213124A1/en not_active Abandoned
- 2018-08-17 US US16/104,434 patent/US10457736B2/en active Active
-
2019
- 2019-05-29 US US16/424,676 patent/US20190375846A1/en not_active Abandoned
- 2019-07-28 IL IL268288A patent/IL268288A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017535257A5 (enExample) | ||
| JP2020531048A5 (enExample) | ||
| JP2020501598A5 (enExample) | ||
| JP2020528750A5 (enExample) | ||
| RU2014101669A (ru) | Агенты, связывающие белки r-спондины (rspo), и способы их применения | |
| JP2021528400A5 (enExample) | ||
| JP2020534250A5 (enExample) | ||
| JP2020536109A5 (enExample) | ||
| JP2019535254A5 (ja) | 抗ｐｄ−ｌ１抗体および変異型 | |
| JP2010535713A5 (enExample) | ||
| JP2015535828A5 (enExample) | ||
| JP2019532056A5 (enExample) | ||
| JP2017521054A5 (enExample) | ||
| JP2014524902A5 (enExample) | ||
| RU2019125975A (ru) | Связывающие агенты | |
| JP2013502913A5 (enExample) | ||
| JP2020514277A5 (enExample) | ||
| JP2017512759A5 (enExample) | ||
| RU2013125306A (ru) | Связывающие протеины, специфичные по отношению к инсулин-подобным факторам роста, и их использование | |
| RU2015142815A (ru) | Лечение рака с использованием антител, связывающихся с поверхностным grp78 | |
| JP2009505676A5 (enExample) | ||
| RU2019104980A (ru) | Анти-icos антитела | |
| JP2020522281A5 (enExample) | ||
| JP2020522280A5 (enExample) | ||
| JP2024520666A5 (enExample) |